当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Journal of Thoracic Oncology杂志
Journal of Thoracic Oncology
基本信息
期刊名称 Journal of Thoracic Oncology
J THORAC ONCOL
期刊ISSN 1556-0864
期刊官方网站 https://www.sciencedirect.com/journal/journal-of-thoracic-oncology
是否OA No
出版商 Elsevier Inc.
出版周期 Monthly
文章处理费 登录后查看
始发年份 2006
年文章数 100
影响因子 21.0(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 ONCOLOGY 肿瘤学1区
RESPIRATORY SYSTEM 呼吸系统2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 36.0 7.879 3.906
Medicine
Pulmonary and Respiratory Medicine
2/155 99%
Medicine
Oncology
11/404 97%
补充信息
自引率 4.3%
H-index 113
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/jto/default.aspx
收稿范围
Official Journal of the International Association for the Study of Lung Cancer

About the Journal

Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance.

Authors are also welcome to submit to the journal?s open access companion title, JTO Clinical and Research Reports, which welcomes a range of manuscripts from subset analyses of published trials to high-quality case reports.
收录体裁
Original Articles
Brief Reports
Editorials/Views/Commentaries
Review Articles
Image(s) or Case(s) of the Month
Gene or Pathway of the Month
Case Reports
Letters to the Editor
投稿指南 https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/publish/guide-for-authors
投稿模板
参考文献格式 https://www.jto.org/content/authorinfo
编辑信息

                                
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug